Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends
Tapan Behl, Sukhbir Singh, Neelam Sharma, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3705-3705
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use
Anna Skrzypczak-Wiercioch, Kinga Sałat
Molecules (2022) Vol. 27, Iss. 17, pp. 5481-5481
Open Access | Times Cited: 120
Brain-targeted Tet-1 peptide-PLGA nanoparticles for berberine delivery against STZ-induced Alzheimer’s disease in a rat model: Alleviation of hippocampal synaptic dysfunction, Tau pathology, and amyloidogenesis
Samar R. Saleh, Aml Abd-Elmegied, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 658, pp. 124218-124218
Closed Access | Times Cited: 12
Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
Yixuan Wang, Hao Hu, Xinyu Liu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 29
Berberine, a natural alkaloid: Advances in its pharmacological effects and mechanisms in the treatment of autoimmune diseases
Zhifang Qin, Ran Tang, Juan Liang, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112422-112422
Closed Access | Times Cited: 8
Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy
Chao Deng, Huanxiao Zhang, Yuxuan Li, et al.
Journal of Colloid and Interface Science (2024) Vol. 671, pp. 354-373
Closed Access | Times Cited: 7
The medicinal plant Berberis aristata and its endophytes for pharmacological applications: Current research and future challenges
Sheetal Sharma, MVNL Chaitanya, Sarika Sharma, et al.
Journal of Applied Biology & Biotechnology (2024)
Open Access | Times Cited: 6
Therapeutic potential and underlying mechanisms of phytoconstituents: emphasizing on resveratol, curcumin, quercetin, berberine, and hesperidin in ulcerative colitis
Tanuj Gangwar, Neelam Poonia, Rudra Narayan Subudhi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Traditional uses, phytochemistry, and pharmacology of Flemingia macrophylla, an important traditional medicinal plant
Muhammad Arif, Ashiq Hussain, Ayesha Najam, et al.
(2025) Vol. 1, Iss. 1
Open Access
Berberine-induced browning and energy metabolism: mechanisms and implications
A. Ağaçdiken, Zeynep Göktaş
PeerJ (2025) Vol. 13, pp. e18924-e18924
Open Access
Understanding the Potential Role of Nanotechnology in Liver Fibrosis: A Paradigm in Therapeutics
Sukhbir Singh, Neelam Sharma, Saurabh Shukla, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2811-2811
Open Access | Times Cited: 15
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management
Sukhbir Singh, Neha Tiwary, Neelam Sharma, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 248-248
Open Access | Times Cited: 4
Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
Wei Wei, Jiuxiu Yao, Tingting Zhang, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 12
Anti-seizure Effects and Mechanisms of Berberine: A Systematic Review
Nahid Jivad, Saeid Heidari-Soureshjani, Hesamaldin Bagheri, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 17, pp. 2253-2265
Closed Access | Times Cited: 3
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Florentina Ioniţă‐Radu, Cristina Patoni, Andreea Simona Nancoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4201-4201
Open Access | Times Cited: 3
Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells
Maryam Jadid Tavaf, Azita Soltanmohammadi, Simin Zargarani, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 8
Characterization and Pharmacokinetic Assessment of a New Berberine Formulation with Enhanced Absorption In Vitro and in Human Volunteers
Julia Solnier, Yiming Zhang, Yun Chai Kuo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2567-2567
Open Access | Times Cited: 7
Thermodynamic Parameters of Berberine with Kolliphor Mixtures Adsorption and Micellization
Magdalena Szaniawska, Katarzyna Szymczyk, Anna Zdziennicka, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3115-3115
Open Access | Times Cited: 6
New insights into mechanisms of berberine in alleviating reproductive disorders of polycystic ovary syndrome: Anti-inflammatory properties
Qing Xia, Wenjing Wang, Zijie Liu, et al.
European Journal of Pharmacology (2022) Vol. 939, pp. 175433-175433
Open Access | Times Cited: 11
Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications
Giuseppe Lisco, Vito Angelo Giagulli, Giovanni De Pergola, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 3, pp. 321-332
Closed Access | Times Cited: 5
Current Evidence of Natural Products Against Overweight and Obesity: Molecular Targets and Mechanisms of Action
Cristina Alicia Elizalde-Romero, Nayely Leyva‐López, Laura Aracely Contreras-Angulo, et al.
(2024)
Open Access | Times Cited: 1
Current Evidence of Natural Products against Overweight and Obesity: Molecular Targets and Mechanisms of Action
Cristina Alicia Elizalde-Romero, Nayely Leyva‐López, Laura Aracely Contreras-Angulo, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 362-379
Open Access | Times Cited: 1
The effects of berberine and curcumin on cardiac, lipid profile and fibrosis markers in cyclophosphamide‐induced cardiac damage: The role of the TRPM2 channel
Zübeyir Huyut, Kenan Yıldızhan, Fikret Altındağ
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 1
Mitochondrial-Targeted Triphenylphosphonium–Hydroxycamptothecin Conjugate and Its Nano-Formulations for Breast Cancer Therapy: In Vitro and In Vivo Investigation
Kunfeng Zhang, Jingxin Fu, Xiaorui Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 388-388
Open Access | Times Cited: 4
Highlighting the Use of the Hepatoprotective Nutritional Supplements among Patients with Chronic Diseases
Monica Foghis, Delia Mirela Ţiţ, Simona Bungău, et al.
Healthcare (2023) Vol. 11, Iss. 19, pp. 2685-2685
Open Access | Times Cited: 3
A review of the role of liposome-encapsulated phytochemicals targeting PPAR Ɣ and associated pathways to combat obesity
Athira P. Shaji, M. A. Jayasri
3 Biotech (2023) Vol. 13, Iss. 9
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top